alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 74, Number 52 (Thursday, March 19, 2009)]
[Notices]
[Page 11740]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-6024]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel. Training Special Emphasis Panel.
    Date: April 2, 2009.
    Time: 12 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852. (Telephone Conference 
Call).
    Contact Person: Shanta Rajaram, PhD, Scientific Review 
Administrator, Scientific Review Branch, Division of Extramural 
Research, NINDS/NIH/DHHS/Neuroscience Center, 6001 Executive Blvd., 
Suite 3208, MSC9529, Bethesda, MD 20852. (301) 435-6033. 
<a href="/cdn-cgi/l/email-protection#eb998a818a998a8698ab868a8287c5858283c58c849d"><span class="__cf_email__" data-cfemail="0173606b6073606c72416c60686d2f6f68692f666e77">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: March 13, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-6024 Filed 3-18-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 15.3



|                                        |                           |                         
|--------------------------------------- | ------------------------- | ------------------------
|TBPE REGISTERED ENGINEERING FIRM F-1580 | FAX (713) 651-0849       
|1100 LOUISIANA        SUITE 4600        | HOUSTON, TEXAS 77002-5294 | TELEPHONE (713) 651-9191



Consent of Ryder Scott Company, L.P.



Ryder Scott Company, L.P.
(“Ryder Scott”) consents to the references to our firm and our report dated March 4, 2015 (our “Report”)
included in Ecopetrol S.A.’s annual report on Form 20-F for the year ended December 31, 2014 (the ”Annual Report”),
the inclusion of our Report as Exhibit April 24, 2015 to the Annual Report and references to and information derived from our Report
in the Annual Report, as well as to the incorporation by reference of this consent and our Report into Ecopetrol’s S.A.’s
registration statement on Form F-3 filed with the United States Securities and Exchange Commission on or about July 26, 2013 (the
“Registration Statement”).  Ryder Scott further consents to the references to Ryder Scott as set forth in the
Registration Statement under the heading “Experts”.



/s/ Ryder Scott
Company, L.P.



RYDER SCOTT COMPANY, L.P.

TBPE Firm Registration No. F-1580



Houston, Texas

April 24, 2015



|SUITE  600,  1015  4TH  STREET, S.W. | CALGARY, ALBERTA T2R 1J4    | TEL (403) 262-2799 | FAX (403) 262-2790
|------------------------------------ | --------------------------- | ------------------ | ------------------
|621  17TH STREET, SUITE 1550         | DENVER, COLORADO 80293-1501 | TEL (303) 623-9147 | FAX (303) 623-4258
[Federal Register Volume 74, Number 53 (Friday, March 20, 2009)]
[Notices]
[Page 11987]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-6172]


-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration


Fourth Plenary Meeting, NextGen Mid-Term Implementation Task 
Force

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of NextGen Mid-Term Implementation Task Force meeting.

-----------------------------------------------------------------------

SUMMARY: The FAA is issuing this notice to advise the public of a 
meeting of the NextGen Mid-Term Implementation Task Force.

DATES: The meeting will be held June 9, 2009 starting at 1 a.m. to 4 
p.m. Arrive in FAA Lobby at 12:30 p.m. for visitor check in.

ADDRESSES: FAA Auditorium, Federal Aviation Administration, 800 
Independence Avenue, SW., Washington, DC 20591.

FOR FURTHER INFORMATION CONTACT: RTCA Secretariat, 1828 L Street, NW., 
Suite 850, Washington, DC 20036; telephone (202) 833-9339; fax (202) 
833-9434; Web site http://www.rtca.org.

SUPPLEMENTARY INFORMATION: Pursuant to section 10(a) (2) of the Federal 
Advisory Committee Act (Pub. L. 92-463, 5 U.S.C., Appendix 2), notice 
is hereby given for a NextGen Mid-Term Implementation Task Force 
meeting. The agenda will include:
    <bullet> Opening Plenary (Welcome and Introductions);
    <bullet> Work Group and Subgroup Status Reports and Planned 
Activities;
    <bullet> Discussion and Next Steps;
    <bullet> Closing Plenary (Other Business, Document Production, Date 
and Place of Next Meeting, Adjourn).
    Attendance is open to the interested public but limited to space 
availability. With the approval of the chairman, members of the public 
may present oral statements at the meeting. Persons wishing to present 
statements or obtain information should contact the person listed in 
the FOR FURTHER INFORMATION CONTACT section. Members of the public may 
present a written statement to the committee at any time.

    Issued in Washington, DC, on March 13, 2009.
Francisco Estrada C.,
RTCA Advisory Committee.
[FR Doc. E9-6172 Filed 3-19-09; 8:45 am]
BILLING CODE 4910-13-P
THE THIRTEENTH COURT OF APPEALS

13-14-00578-CV

Carlos & Emily Enterprises, Inc., and Carlos Garcia, Individually, D/B/A Express 

International

v.

Jose Luis Martinez

On Appeal from the

County Court at Law No. 8 of Hidalgo County, Texas

Trial Cause No. CL-09-0030-H

JUDGMENT

THE THIRTEENTH COURT OF APPEALS, having considered this cause on 

appeal, concludes the appeal should be dismissed. The Court orders the appeal 

DISMISSED in accordance with its opinion. Costs of the appeal are adjudged against 

appellant.

We further order this decision certified below for observance.

January 22, 2015
DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FOURTH DISTRICT

JACOB FRANCOIS,

Appellant,

v.

LIBRARY SQUARE ASSOCIATION, INC.,

Appellee.

No. 4D17-2694

[July 11, 2018]

Appeal from the Circuit Court for the Seventeenth Judicial Circuit, 

Broward County; Martin J. Bidwill, Judge; L.T. Case No. CACE-16-

001715(05).

Jacob Francois, Port St. Lucie, pro se.

Joseph B. Lancos of Tripp Scott, P.A., Fort Lauderdale, for appellee.

PER CURIAM.

The trial court erred when it denied the defendant’s motion to set aside 

the foreclosure sale. We vacate the sale and remand. 

Following entry of final judgment of foreclosure, the defendant filed a 

timely motion for rehearing. While his motion for rehearing was pending, 

the clerk of court enforced the final judgment by conducting a foreclosure 

auction and selling the property to the highest bidder (a third party). The 

defendant’s subsequent motion to set aside the sale was denied. 

While a motion for rehearing is pending, the trial court retains 

“complete control of its decree with the power to alter or change it . . . . ” 

State ex rel. Owens v. Pearson, 156 So. 2d 4, 7 (Fla. 1963). For this reason, 

it is well settled that “enforcement of a final judgment is suspended” by 

the filing of a timely motion for rehearing. 944 CWELT-2007 LLC v. Bank 

of Am., N.A., 194 So. 3d 470, 471 (Fla. 3d DCA 2016).

Here, the foreclosure sale must be set aside because it was conducted 

while the defendant’s timely motion for rehearing directed at the 
2

foreclosure judgment was pending. See, e.g., Diaz v. U.S. Bank, N.A., 239 

So. 3d 151, 152 (Fla. 3d DCA 2018). 

The defendant also appeals the trial court’s eventual denial of his 

motion for rehearing. We affirm the denial of his motion for rehearing and 

reverse only the order denying his motion to set aside the sale for the 

reasons stated. We vacate the foreclosure sale and remand for the court 

to begin the sale process anew. See Hoffman v. BankUnited, N.A., 137 So. 

3d 1039 (Mem) (Fla. 2d DCA 2014).

GERBER, C.J., GROSS and CIKLIN, JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
**Exhibit 31.1**
Certification of Principal Executive Officer
I, Peter A. Edison, certify that:
1. I have reviewed this quarterly report on Form 10-Q/A of Bakers FootwearGroup, Inc.; 2. Based on my knowledge, this report does not contain any untruestatement of a material fact or omit to state a material fact necessaryto make the statements made, in light of the circumstances under whichsuch statements were made, not misleading with respect to the periodcovered by this report; 3. Based on my knowledge, the financial statements, and other financialinformation included in this report, fairly present in all materialrespects the financial condition, results of operations and cash flowsof the registrant as of, and for, the periods presented in this report; 4. The registrant’s other certifying officers and I are responsible forestablishing and maintaining disclosure controls and procedures (asdefined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for theregistrant and have:
(a) Designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under oursupervision, to ensure that material information relating to theregistrant, including its consolidated subsidiaries, is made knownto us by others within those entities, particularly during theperiod in which this report is being prepared;
(b) [reserved]
(c) Evaluated the effectiveness of the registrant’s disclosurecontrols and procedures and presented in this report our conclusionsabout the effectiveness of the disclosure controls and procedures,as of the end of the period covered by this report based on suchevaluation; and
(d) Disclosed in this report any change in the registrant’s internalcontrol over financial reporting that occurred during theregistrant’s most recent fiscal quarter (the registrant’s fourthfiscal quarter in the case of an annual report) that has materiallyaffected, or is reasonably likely to materially affect, theregistrant’s internal control over financial reporting; and
5. The registrant’s other certifying officers and I have disclosed,based on our most recent evaluation of internal control over financialreporting, to the registrant’s auditors and the audit committee of theregistrant’s board of directors (or persons performing the equivalentfunctions):
(a) All significant deficiencies and material weaknesses in thedesign or operation of internal control over financial reportingwhich are reasonably likely to adversely affect the registrant’sability to record, process, summarize and report financialinformation; and
(b) Any fraud, whether or not material, that involves management orother employees who have a significant role in the registrant’sinternal control over financial reporting.         March 21, 2005 /s/ Peter A. Edison   Peter A. Edison   Chairman of the Board and
**Exhibit 32.2**

 

CERTIFICATIONPURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with theQuarterly Report of Uni-Pixel, Inc. (the “Company”) on Form 10-Q forthe quarter ending March 31, 2010 as filed with the Securities andExchange Commission on the date hereof (the “Report”), I, Jeffrey Tomz,Principal Financial Officer of the Company, hereby certify, pursuant to 18U.S.C. Section 1350, as adopted pursuant to Section 906 of theSarbanes-Oxley Act of 2002, that:

 

·              The Report fully complies with the requirements ofsection 13(a) or 15(d) of the Securities Exchange Act of 1934(15 U.S.C 78m or 78o(d)); and

·              The information contained in the Report fairlypresents, in all material respects, the financial condition and results ofoperations of the Company.

 
| Date:  | May 10, 2010 | By:    | /s/ Jeffrey Tomz                           |
|--------|-------------------|--------|--------------------------------------------|
|   |              |   | Jeffrey Tomz, Principal  Financial Officer |

 

*A signed original of this writtenstatement required by Section 906 of the Sarbanes-Oxley Act of 2002 hasbeen provided to Uni-Pixel, Inc. and will be retained by Uni-Pixel, Inc.and furnished to the Securities and Exchange Commission or its staff uponrequest.  The foregoing certification isbeing furnished solely pursuant to 18 U.S.C. Section 1350 and shall not bedeemed  filed by the Company for purposesof Section 18 of the Securities Exchange Act of 1934, as amended.*

 

----
AAM-12-469-E August 6, 2012 Exemption No. 9782B Regulatory Docket No. FAA-2008-0710

Ms. Pamela Goss Designated Employer Representative JAARS, Inc.

P.O. Box 248 Waxhaw, NC 28173

Dear Ms. Goss:

This letter is to inform you that we have granted your petition to extend Exemption No. 9782. It explains the basis for our decision, describes its effect, and lists the conditions

and limitations.

The Basis for Our Decision

By letter dated July 9, 2012, you petitioned the Federal Aviation Adm inistration (FAA) on behalf of JAARS, Inc. (JAARS), for an extension of Exemption No. 9782. That exemption from part 120 of Title 14, Code of Federal Regulations allows JAARS which is operating under separate parts of the regulations, to cover its safety-sensitive employees under one testing program.

In your petition, you indicate that there has been no change in the conditions and reasons relative to public interest and safety that were the basis for granting the original exemption.

The FAA has determined that good cause exists for not publishing a summary of the petition

in the Federal Register because the requested extension of the exemption would not set a precedent, and any delay in acting on this petition would be detrimental to JAARS.2

Our Decision

The FAA has determ ined that the justification for the issuance of Exemption No. 9782 remains valid with respect to this exemption and is in the public interest. Therefore, under the authority provided by 49 U.S.C. 40113 and 44701, which the FAA Administrator has delegated to me, I grant your petition, subject to the following conditions and limitations.

Conditions and Limitations

1. Employees of JAARS are subject to the drug and alcohol regulations at all times while conducting operations under part 135 or part 91.

2. The drug and alcohol testing program must be implemented under the auspices of the JAARS part 135 operation, not under part 91.

The Effect of Our Decision

Our decision extends the term ination date of Exemption No. 9782 to November 30, 2014, unless sooner superseded or rescinded.

Sincerely,

/s/

James R. Fraser Deputy Federal Air Surgeon
[No. 51764-3-I.

Division One.

June 7, 2004.]

#### The State of Washington, *Respondent,*v. Bruce Dennis Kellerman, *Appellant.*

Appeal from a judgment of the Superior Court for Sno-homish County, No. 02-1-00328-6, Ellen J. Fair, J., entered December 20, 2002. *Affirmed*by unpublished opinion per Kennedy, J., concurred in by Coleman and Agid, JJ.
Exhibit 32.1



CERTIFICATION OF CHIEF EXECUTIVE OFFICER
AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002



The following certifications are
being furnished solely to accompany the Annual Report on Form 10-K for the year ended June 30, 2017 (the
“Report”) pursuant to U.S.C. Section 1350, and pursuant to SEC Release No. 33-8238 are being
“furnished” to the SEC rather than “filed” either as part of the Report or as a separate disclosure
statement, and are not to be incorporated by reference into the Report or any other filing of Wearable Healthcare Solutions,
Inc. (the “Company”), whether made before or after the date hereof, regardless of any general incorporation
language in such filing. The following certifications shall not be deemed “filed” for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under that section.



Certification of the Chief Executive Officer



Pursuant to 18 U.S.C. Section 1350, as created
by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of the Company hereby certifies, to such officer’s
knowledge, that:



(i) the Report fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and



(ii) the information contained in the Report
fairly presents, in all material respects, the financial condition and results operations of the Company as of, and for, the periods
presented in such Report.



|Date: | August 24, 2018 | By: | /s/ Daniel Sobolowski                                                                                                       
|----- | --------------- | --- | ----------------------------------------------------------------------------------------------------------------------------
|      |                 |     | Name: Daniel Sobolowski
        Title: President, Chief Executive Officer and Director
        (Principal Executive Officer)



Certification of the Chief Financial Officer



Pursuant to 18 U.S.C. Section 1350, as created
by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of the Company hereby certifies, to such officer’s
knowledge, that:



(i) the Report fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and



(ii) the information contained in the Report
fairly presents, in all material respects, the financial condition and results operations of the Company as of, and for, the periods
presented in such Report.



|Date: | August 24, 2018 | By: | /s/ Daniel Sobolowski                                                                                              
|----- | --------------- | --- | -------------------------------------------------------------------------------------------------------------------
|      |                 |     | Name: Daniel Sobolowski
        Title: Chief Financial Officer
        (Principal Financial and Accounting Officer)
##### 



Exhibit 32.1 CERTIFICATION OF
CURTIS W. MEWBOURNE/CHIEF EXECUTIVE OFFICER
OF MEWBOURNE DEVELOPMENT CORPORATION
PURSUANT TO 18 U.S.C. § 1350 I, Curtis W. Mewbourne, Chief Executive Officer of Mewbourne Development
Corporation, Managing General Partner of Mewbourne Energy Partners 03-A, L.P.,
(the Registrant), hereby certify that the accompanying report on Form 10-Q,
for the quarterly period ended June 30, 2004 and filed with the Securities and
Exchange Commission on the date hereof pursuant to Section 13(a) of the
Securities Exchange Act of 1934 (the Report) by the Registrant fully complies
with the requirements of that section. I further certify that the information contained in the Report fairly
presents, in all material respects, the financial condition and results of
operations of the Registrant. /s/ Curtis W. MewbourneName:
    
    Curtis W. MewbourneDate:
    
    August 13, 2004
Exhibit 13.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANESOXLEY ACT OF 2002

In connection with the Annual Report on Form 20-F of Acasti Pharma Inc. (the Company) for
the fiscal year ended March 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Linda P. OKeefe, Principal Financial Officer of the Company certify pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



|1. | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of
1934, as amended; and
|-- | ---------------------------------------------------------------------------------------------------------------------------------



|2. | The information contained in the Report fairly presents, in all material respects, the financial condition and
results of operations of the Company.
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------

Date: June 27, 2017



|                                   |  | 
|---------------------------------- |  | 
|/s/ Linda P. OKeefe               |  | 
|Name: Linda P. OKeefe             |  | 
|Title: Principal Financial Officer |  |
EXHIBIT 32.1

               CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350,
                       AS ADOPTED PURSUANT TO SECTION 906
                        OF THE SARBANES-OXLEY ACT OF 2002


The undersigned  hereby certifies in his capacity as Chief Executive  Officer of
Belrose Capital Fund LLC (the "Fund"), that:

(a)  the  quarterly  Report of the Fund on Form 10-Q for the quarter  ended June
     30, 2003 (the  "Report")  fully complies with the  requirements  of Section
     13(a) of the Securities Exchange Act of 1934, as amended; and

(b)  the information  contained in the Report fairly  presents,  in all material
     respects, the financial condition and the results of operations of the Fund
     for such period.



Date:  August 14, 2003

                                        /s/ Thomas E. Faust Jr.
                                        -----------------------
                                        Thomas E. Faust Jr.
                                        Chief Executive Officer
[No. 51709-1-I.

Division One.

June 1, 2004.]

#### The State of Washington, *Respondent,*v. Manuel Gonzales, *Appellant.*

Appeal from a judgment of the Superior Court for Kang County, No. 02-1-07250-6, Donald D. Haley, J., entered January 22, 2003. *Affirmed*by unpublished per curiam opinion.